Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...

Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...

Seigerman said that Pfizer's consistent commercial progress drove the fourth-quarter beat, but investors will likely focus on the company's drug pipeline and returns from its 2023 acquisition of ...

Following our analysis of the options activities associated with Pfizer, we pivot to a closer look at the company's own performance ... reveals his one-line chart technique that shows when ...

Pharmaceutical giant Pfizer (NYSE: PFE) is trading near its lowest price in over a decade. The company's revenue and profits ballooned during the pandemic on its COVID-19 vaccine and treatment.

WALTHAM, MASSACHUSETTS / ACCESS Newswire / February 4, 2025 / Data4Cure today announced an ongoing multi-year partnership with Pfizer ... a leading biomedical AI company specializing in biology ...